share_log

Assure | 8-K: Current report

Assure | 8-K: Current report

Assure | 8-K：重大事件
美股sec公告 ·  05/21 12:46
Moomoo AI 已提取核心信息
Assure Holdings Corp., a provider of intraoperative neuromonitoring services, has announced a series of significant corporate developments. On April 8, 2024, the company's Board of Directors approved an amendment to increase the authorized shares of common stock from 9 million to 250 million, which was subsequently approved by stockholders on May 14, 2024. The Certificate of Amendment was filed with the State of Nevada on May 17, 2024, to effectuate the increase. Additionally, Assure has received a decision from the Nasdaq Hearings Panel granting an extension until July 22, 2024, to regain compliance with Nasdaq's listing requirements in relation to its upcoming transaction with Danam Health Inc. This news was released in a press statement on May 16, 2024. Furthermore, Assure has scheduled a webinar presentation for stockholders and investors, as announced in a press release on May 17, 2024. These announcements come in the context of a proposed transaction between Assure and Danam Health Inc., for which materials have been filed with the SEC, including a registration statement containing a prospectus and a proxy statement.
Assure Holdings Corp., a provider of intraoperative neuromonitoring services, has announced a series of significant corporate developments. On April 8, 2024, the company's Board of Directors approved an amendment to increase the authorized shares of common stock from 9 million to 250 million, which was subsequently approved by stockholders on May 14, 2024. The Certificate of Amendment was filed with the State of Nevada on May 17, 2024, to effectuate the increase. Additionally, Assure has received a decision from the Nasdaq Hearings Panel granting an extension until July 22, 2024, to regain compliance with Nasdaq's listing requirements in relation to its upcoming transaction with Danam Health Inc. This news was released in a press statement on May 16, 2024. Furthermore, Assure has scheduled a webinar presentation for stockholders and investors, as announced in a press release on May 17, 2024. These announcements come in the context of a proposed transaction between Assure and Danam Health Inc., for which materials have been filed with the SEC, including a registration statement containing a prospectus and a proxy statement.
术中神经监测服务提供商Assure Holdings Corp. 宣布了一系列重大的公司发展。2024 年 4 月 8 日，公司董事会批准了一项修正案，将普通股的授权股数从 900 万股增加到 2.5 亿股，该修正案随后于 2024 年 5 月 14 日获得股东的批准。修正证书于2024年5月17日向内华达州提交，以使上调生效。此外，Assure已收到纳斯达克听证会小组的决定，批准将期限延长至2024年7月22日，以恢复遵守纳斯达克即将与达南健康公司进行的交易的上市要求。该消息在2024年5月16日的新闻声明中发布。此外，正如在2024年5月17日的新闻稿中宣布的那样，Assure已计划为股东和投资者举办网络研讨会演讲。这些公告是在Assure和Danam Health Inc. 之间拟议交易的背景下发布的，该交易的材料已向美国证券交易委员会提交，包括一份包含招股说明书和委托书的注册声明。
术中神经监测服务提供商Assure Holdings Corp. 宣布了一系列重大的公司发展。2024 年 4 月 8 日，公司董事会批准了一项修正案，将普通股的授权股数从 900 万股增加到 2.5 亿股，该修正案随后于 2024 年 5 月 14 日获得股东的批准。修正证书于2024年5月17日向内华达州提交，以使上调生效。此外，Assure已收到纳斯达克听证会小组的决定，批准将期限延长至2024年7月22日，以恢复遵守纳斯达克即将与达南健康公司进行的交易的上市要求。该消息在2024年5月16日的新闻声明中发布。此外，正如在2024年5月17日的新闻稿中宣布的那样，Assure已计划为股东和投资者举办网络研讨会演讲。这些公告是在Assure和Danam Health Inc. 之间拟议交易的背景下发布的，该交易的材料已向美国证券交易委员会提交，包括一份包含招股说明书和委托书的注册声明。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息